Novel Agents and Complementary Therapies for Chronic Pain
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (30 June 2019) | Viewed by 18426
Special Issue Editor
Special Issue Information
Dear Colleagues,
Chronic pain is a major global health burden that affects more than 20% of the population, resulting in an enormous socio-economic burden. This debilitating condition often manifests as hypersensitivity to sensory input, so a normally innocuous stimulus can be painful or a moderately noxious stimulus produces excessive pain. Analgesics that are currently in use for chronic pain only provide pain relief in a small proportion of patients. Long-term use of many pain therapeutics is limited due to the development of tolerance, addiction and side effects such as drowsiness, respiratory depression and gastrointestinal ulceration. There is an urgent need for safer and more effective drugs for chronic pain management. This Special Issue of Medicines will focus on novel agents and complementary therapies for the treatment of chronic pain conditions. Research articles and reviews relating to potential therapeutic agents or therapies to treat pain, including those in animal models or humans, will be covered.
Prof. Dr. Wendy L. Imlach
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Pain
- Nociception
- Analgesic
- Chronic or pathological pain
- Painkillers
- Novel therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
